Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus

Transplantation

Volumn 82, Issue 12, 2006, Pages 1698-1702

  Sifontis, Nicole M ^a   Coscia, Lisa A ^b   Constantinescu, Serban ^b   Lavelanet, Antonella F ^c   Moritz, Michael J ^d   Armenti, Vincent T ^b  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^d LEHIGH VALLEY HOSPITAL   (United States)

Author keywords

Mycophenolate mofetil; Pregnancy; Sirolimus

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; AMLODIPINE; AZATHIOPRINE; AZTREONAM; CLINDAMYCIN; CORTICOSTEROID; CYCLOSPORIN A; ERYTHROPOIETIN; FUROSEMIDE; GANCICLOVIR; IRON; LABETALOL; METOPROLOL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OMEPRAZOLE; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; VITAMIN;

CHEMICAL TERATOGENESIS; CLEFT LIP; CLEFT PALATE; CLINICAL ARTICLE; CONFERENCE PAPER; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CONTROLLED STUDY; CRANIOFACIAL MALFORMATION; DIAPHRAGM HERNIA; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FINGER MALFORMATION; FRYNS SYNDROME; GRAFT RECIPIENT; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERVIEW; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; LIVE BIRTH; LIVER TRANSPLANTATION; MEDICAL RECORD REVIEW; MICROTIA; NAIL HYPOPLASIA; NEWBORN; NEWBORN DEATH; ORGAN TRANSPLANTATION; PREGNANCY OUTCOME; PREMATURITY; PRENATAL DRUG EXPOSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGENY; QUESTIONNAIRE; REGISTER; SECOND TRIMESTER PREGNANCY; SIDE EFFECT; SPONTANEOUS ABORTION; TELEPHONE; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ADULT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; MYCOPHENOLIC ACID; ORGAN TRANSPLANTATION; PREGNANCY; PREGNANCY OUTCOME; REGISTRIES; SIROLIMUS;

EID: 33845952539     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000252683.74584.29     Document Type: Conference Paper

References (17)

1. Sollinger HW, for the U.S. Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995; 60: 225.
2. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection. Lancet 1995; 345: 1321.
3. Kahan BD, for the Rapamune US Study Group. Efficacy of sirolimus compared with azathioprine for the reduction of acute renal allograft rejection: a randomized multicentre study. Lancet 2000; 356: 194.
4. Mycophenolate package insert. Nutley, NJ: Roche laboratories. 2005.
5. Armenti VT, Moritz MJ, Cardonick EH, Davison JM. Immunosuppression in Pregnancy: Choices for infant and maternal health. Drugs 2002; 62(16): 2361.
6. Mastrobattista JM, Katz AR. Pregnancy after organ transplant. Obstet Gynecol Clin N Am 2004; 31: 415.
7. Tendron A, Gouyon JB, Decramer S. In vitro exposure to immunosuppressive drugs: experimental and clinical studies. Pediatr Nephrol 2002; 17: 121.
8. Sirolimus package insert. Philadelphia, PA: Wyeth Laboratories. 2005.
9. Pérgola PE, Kancharla A, Riley DJ. Kidney transplantation during the first trimester of pregnancy: immunosuppression with mycophenolate mofetil, tacrolimus and prednisone. Transplantation 2001; 71: 994.
10. Armenti VT, Radomski JS, Moritz MJ, et al. Report from the National Transplantation Pregnancy Registry (NTPR): Outcomes of pregnancy after transplantation. In: Clinical Transplants 2003, Cecka JM and Terasaki PI (eds), UCLA Immunogenetics Center, Los Angeles, CA, 2005.
11. McKay DB, Josephson MA. Medical Progress: Pregnancy in recipients of solid organs-effects on mother and child. NEJM 2006; 354(12): 1281.
12. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV. 10. Long-term management of the transplant recipient- pregnancy in renal transplant recipients. Nephrol Dial Transplant 2002; 17: Suppl 4: 50.
13. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. Seventh Edition. 2005.
14. Beahm EK, Walton RL. Auricular Reconstruction for Microtia: Part 1. Anatomy, Embryology and Clinical Evaluation. Plastic and Reconstructive Surgery 2002; 109(7): 2473.
15. LeRay C, Coulomb A, Elefant E, Frydman R, Audibert F. Mycophenolate Mofetil in pregnancy after renal transplantation: A case of major fetal malformations. Obstet Gynecol 2004; 103: 1091.
16. Jankowska I, Oldakowska-Jedynak U, Jabiry-Zieniewicz A, et al. Absence of teratogenicity of sirolimus used during early pregnancy in a liver transplant recipient. Transplant Proc 2004; 36: 3232.
17. Guardia O, del C. Rial M, Casadei D. Pregnancy under sirolimus immunosuppression. Transplantation 2006; 81(4): 636.